NO893256L - Fremgangsmaate for fremstilling av furyltiazolderivater. - Google Patents
Fremgangsmaate for fremstilling av furyltiazolderivater.Info
- Publication number
- NO893256L NO893256L NO89893256A NO893256A NO893256L NO 893256 L NO893256 L NO 893256L NO 89893256 A NO89893256 A NO 89893256A NO 893256 A NO893256 A NO 893256A NO 893256 L NO893256 L NO 893256L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- derivatives
- furyltiazold
- procedure
- ulcer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Polyurethanes Or Polyureas (AREA)
- Polyesters Or Polycarbonates (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888819365A GB8819365D0 (en) | 1988-08-15 | 1988-08-15 | New furylthiazole derivatives processes for preparation thereof & pharmaceutical composition comprising same |
| GB898905818A GB8905818D0 (en) | 1989-03-14 | 1989-03-14 | New furylthiazole derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO893256D0 NO893256D0 (no) | 1989-08-14 |
| NO893256L true NO893256L (no) | 1990-02-16 |
Family
ID=26294284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89893256A NO893256L (no) | 1988-08-15 | 1989-08-14 | Fremgangsmaate for fremstilling av furyltiazolderivater. |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0355612B1 (no) |
| JP (1) | JP2814594B2 (no) |
| KR (1) | KR900003166A (no) |
| CN (1) | CN1040796A (no) |
| AT (1) | ATE109144T1 (no) |
| AU (1) | AU3934689A (no) |
| DE (1) | DE68917049T2 (no) |
| DK (1) | DK391089A (no) |
| FI (1) | FI893795A7 (no) |
| IL (1) | IL91152A0 (no) |
| NO (1) | NO893256L (no) |
| PT (1) | PT91415B (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL95548A0 (en) * | 1989-09-15 | 1991-06-30 | Fujisawa Pharmaceutical Co | Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same |
| EP0598906A1 (en) * | 1991-08-02 | 1994-06-01 | Fujisawa Pharmaceutical Co., Ltd. | Furylthiazole and their use as h 2?-receptor antagonism and antimicrobial |
| GB9211163D0 (en) * | 1992-05-26 | 1992-07-08 | Fujisawa Pharmaceutical Co | New oxazole derivatives |
| GB9326611D0 (en) * | 1993-12-31 | 1994-03-02 | Fujisawa Pharmaceutical Co | New compound |
| DE102004008141A1 (de) | 2004-02-19 | 2005-09-01 | Abbott Gmbh & Co. Kg | Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren |
| WO2016098793A1 (ja) * | 2014-12-17 | 2016-06-23 | 塩野義製薬株式会社 | 環状グアニジル基を有するチアゾール誘導体 |
| EP4196793A1 (en) | 2020-08-11 | 2023-06-21 | Université de Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4315009A (en) * | 1978-01-18 | 1982-02-09 | Imperial Chemical Industries Limited | Antisecretory guanidine derivatives and pharmaceutical compositions containing them |
| JPS59225186A (ja) * | 1983-05-18 | 1984-12-18 | Yamanouchi Pharmaceut Co Ltd | 新規なグアニジノチアゾ−ル誘導体及びその製造方法 |
| US4560690A (en) * | 1984-04-30 | 1985-12-24 | Pfizer Inc. | 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents |
| JPS62273977A (ja) * | 1986-05-21 | 1987-11-28 | Yoshitomi Pharmaceut Ind Ltd | フリルチアゾ−ル化合物 |
| US4814341A (en) * | 1986-08-26 | 1989-03-21 | Reiter Lawrence A | 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents |
-
1989
- 1989-07-28 IL IL91152A patent/IL91152A0/xx unknown
- 1989-08-04 AU AU39346/89A patent/AU3934689A/en not_active Abandoned
- 1989-08-09 PT PT91415A patent/PT91415B/pt not_active IP Right Cessation
- 1989-08-09 DK DK391089A patent/DK391089A/da not_active Application Discontinuation
- 1989-08-11 JP JP1208801A patent/JP2814594B2/ja not_active Expired - Lifetime
- 1989-08-11 EP EP89114869A patent/EP0355612B1/en not_active Expired - Lifetime
- 1989-08-11 AT AT89114869T patent/ATE109144T1/de not_active IP Right Cessation
- 1989-08-11 DE DE68917049T patent/DE68917049T2/de not_active Expired - Fee Related
- 1989-08-11 FI FI893795A patent/FI893795A7/fi not_active Application Discontinuation
- 1989-08-14 KR KR1019890011669A patent/KR900003166A/ko not_active Withdrawn
- 1989-08-14 CN CN89106495A patent/CN1040796A/zh active Pending
- 1989-08-14 NO NO89893256A patent/NO893256L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0355612A2 (en) | 1990-02-28 |
| DK391089A (da) | 1990-02-16 |
| JP2814594B2 (ja) | 1998-10-22 |
| KR900003166A (ko) | 1990-03-23 |
| PT91415B (pt) | 1995-05-04 |
| EP0355612B1 (en) | 1994-07-27 |
| PT91415A (pt) | 1990-03-08 |
| AU3934689A (en) | 1990-02-15 |
| DE68917049D1 (de) | 1994-09-01 |
| JPH0272177A (ja) | 1990-03-12 |
| DK391089D0 (da) | 1989-08-09 |
| EP0355612A3 (en) | 1990-08-22 |
| NO893256D0 (no) | 1989-08-14 |
| IL91152A0 (en) | 1990-03-19 |
| CN1040796A (zh) | 1990-03-28 |
| DE68917049T2 (de) | 1995-01-05 |
| FI893795A7 (fi) | 1990-02-16 |
| ATE109144T1 (de) | 1994-08-15 |
| FI893795A0 (fi) | 1989-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK275585A (da) | Hidtil ukendte calciumsalte | |
| NO874955L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater. | |
| FI885488L (fi) | 2,2-difluorisyklopropyylietaanijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö tuholaisten torjunta-aineina | |
| RU93032613A (ru) | Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата | |
| NO171909C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater | |
| DK164441C (da) | Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande | |
| DK0668077T3 (da) | Produkter, som indeholder G-CSF og TNF-bindende protein | |
| NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
| DK393188A (da) | Farmaceutisk praeparat til intranasal administrering | |
| NO165071C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre. | |
| NO862534L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-oxy-4h-3,1-benzoxazin-4-on-derivater og beslektede forbindelser. | |
| NO167734C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater. | |
| NO902710L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive r(-) 3-kinuklidinol-derivater. | |
| NO893256L (no) | Fremgangsmaate for fremstilling av furyltiazolderivater. | |
| ATE88084T1 (de) | Verwendung eines gemisches zur behandlung der alopezie. | |
| IT8721115A0 (it) | Fitopreparato per la cura di affezioni cutanee. | |
| ZA845682B (en) | Benzamidine derivatives having an antimicrobial activity process for their preparation and use as disinfectant drugs or preservatives | |
| NO167456C (no) | Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse 7-(3-amino-1-pyrrolidinyl)-8-brom-1-syklopropyl-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre | |
| NO880292D0 (no) | Fremgangsmaate for behandling av humle. | |
| NO172491C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater | |
| NO167801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater. | |
| NO881798D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| RU92016264A (ru) | Новые соединения, способ их получения, фармацевтический состав, его получение, способ профилактики или лечения, применение соединений | |
| NO900616L (no) | Fremgangsmaate for fraksjonering av avlinger i industrieltraamateriale. | |
| NO890328D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 4-amino-2,3-disubstituert-6,7-dihydro-5h-1-pyrindinderivater. |